StockNews.com assumed coverage on shares of Senseonics (NYSE:SENS – Free Report) in a research report sent to investors on Monday morning. The firm issued a sell rating on the stock.
Senseonics Stock Performance
Senseonics stock opened at $0.39 on Monday. The stock has a market cap of $206.20 million, a P/E ratio of -2.77 and a beta of 0.82. The company has a current ratio of 3.96, a quick ratio of 3.70 and a debt-to-equity ratio of 1.79. The stock has a 50 day moving average of $0.44 and a 200-day moving average of $0.54. Senseonics has a 52 week low of $0.37 and a 52 week high of $1.05.
Senseonics (NYSE:SENS – Get Free Report) last released its earnings results on Monday, May 13th. The company reported ($0.03) EPS for the quarter, meeting the consensus estimate of ($0.03). The company had revenue of $5.05 million during the quarter, compared to analysts’ expectations of $4.76 million. Senseonics had a negative return on equity of 202.32% and a negative net margin of 346.38%. On average, analysts expect that Senseonics will post -0.13 EPS for the current fiscal year.
Hedge Funds Weigh In On Senseonics
About Senseonics
Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.
Read More
- Five stocks we like better than Senseonics
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Outlook Therapeutics: Analysts Forecast Over 500% Stock Upside
- Find and Profitably Trade Stocks at 52-Week Lows
- Campbell Soup Co. Targets Fiscal Q4 Stock Recovery
- Do ETFs Pay Dividends? What You Need to Know
- Zebra Analysts Upgrade Stock, Forecasting Major Reversal
Receive News & Ratings for Senseonics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics and related companies with MarketBeat.com's FREE daily email newsletter.